InvestorsHub Logo
Followers 12
Posts 588
Boards Moderated 0
Alias Born 10/18/2010

Re: mckvee post# 10632

Tuesday, 10/15/2019 5:32:02 PM

Tuesday, October 15, 2019 5:32:02 PM

Post# of 13089
nice try in defending your buddy. The majority of his messages are derogatory, and some have been clearly racist. We all question company decisions and lack of progress. That's definitely part of the investing analyses process. It's the continued multi-daily belligerent comments with no basis and certainly no understanding of the issues that the company with FDA cleared technology has to hurdle and weave through. It is painful to watch this guy do this to himself every day.
I'll not make excuses for ALRT but I've been in this space for years and change comes so slowly. LVGO is different because it's patient centric, fewer barriers to entry. But I'm glad ALRT is not patient centric. IMO ALRT is set for long term growth whereas LVGO has limited growth potential in the diabetes segment. In two years I estimate ALRT will have 5 times more diabetes patients on their platform than LVGO will have.